EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High-throughput screening of novel TFEB agonists in protecting against acetaminophen-induced liver injury in mice

Xiaojuan Chao, Mengwei Niu, Shaogui Wang, Xiaowen Ma, Xiao Yang, Hua Sun, Xujia Hu, Hua Wang, Li Zhang, Ruili Huang, Menghang Xia, Andrea Ballabio und 3 weitere

Acta Pharmaceutica Sinica B · 2024-01 · 14 (1) · 190-206

DOI: 10.1016/j.apsb.2023.10.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-01. Verfasst von Xiaojuan Chao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Veterinärmedizinische Universität Wien, Medizinische Universität Graz, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macroautophagy (referred to as autophagy hereafter) is a major intracellular lysosomal degradation pathway that is responsible for the degradation of misfolded/damaged proteins and organelles. Previous studies showed that autophagy protects against acetaminophen (APAP)-induced injury (AILI) via selective removal of damaged mitochondria and APAP protein adducts. The lysosome is a critical organelle sitting at the end stage of autophagy for autophagic degradation via fusion with autophagosomes. In the present study, we showed that transcription factor EB (TFEB), a master transcription factor for lysosomal biogenesis, was impaired by APAP resulting in decreased lysosomal biogenesis in mouse livers. Genetic loss-of and gain-of function of hepatic TFEB exacerbated or protected against AILI, respectively. Mechanistically, overexpression of TFEB increased clearance of APAP protein adducts and mitochondria biogenesis as well as SQSTM1/p62-dependent non-canonical nuclear factor erythroid 2-related factor 2 (NRF2) activation to protect against AILI. We also performed an unbiased cell-based imaging high-throughput chemical screening on TFEB and identified a group of TFEB agonists. Among these agonists, salinomycin, an anticoccidial and antibacterial agent, activated TFEB and protected against AILI in mice. In conclusion, genetic and pharmacological activating TFEB may be a promising approach for protecting against AILI.

Schlagwörter

Stichwörter der Autor:innen

AutophagyDILIDrug screeningHepatotoxicityLysosomeMitochondriaMitophagyNRF2

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei 230032, China.
  • National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
  • Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples 80131, Italy.
  • Medical Genetics, Department of Translational Medicine, Federico II University, Naples 80131, Italy.

Förderung

  • Veterinärmedizinische Universität Wien
  • Medizinische Universität Graz
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Chao, X., Niu, M., Wang, S., Ma, X., Yang, X., Sun, H., Hu, X., Wang, H., Zhang, L., Huang, R., Xia, M., Ballabio, A., Jaeschke, H., Ni, H. M., & Ding, W. X. (2024). High-throughput screening of novel TFEB agonists in protecting against acetaminophen-induced liver injury in mice. Acta Pharmaceutica Sinica B, 14(1), 190-206. https://doi.org/10.1016/j.apsb.2023.10.017

Vancouver

Chao X, Niu M, Wang S, Ma X, Yang X, Sun H, et al. High-throughput screening of novel TFEB agonists in protecting against acetaminophen-induced liver injury in mice. Acta Pharmaceutica Sinica B. 2024;14(1):190-206. doi:10.1016/j.apsb.2023.10.017

BibTeX
@article{Chao2024,
  author = {Chao, Xiaojuan and Niu, Mengwei and Wang, Shaogui and Ma, Xiaowen and Yang, Xiao and Sun, Hua and Hu, Xujia and Wang, Hua and Zhang, Li and Huang, Ruili and Xia, Menghang and Ballabio, Andrea and Jaeschke, Hartmut and Ni, Hong-Min and Ding, Wen-Xing},
  title = {High-throughput screening of novel TFEB agonists in protecting against acetaminophen-induced liver injury in mice},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {190--206},
  doi = {10.1016/j.apsb.2023.10.017}
}
Kostenlos starten →